title: Horizontal transmission dynamics of a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus and the effect of vaccination on transmission of virulent virus.
abstract: Infectious laryngotracheitis virus (ILTV) is an alphaherpesvirus that causes acute respiratory disease in chickens worldwide. The virus is horizontally transmitted and causes large outbreaks of disease. Recent studies have shown that a glycoprotein G deficient candidate vaccine strain of ILTV (ΔgG ILTV) is safe and protects birds from disease following challenge with virulent virus. This study examined the transmission dynamics of this candidate vaccine and of ILTV in field and experimental settings. The reproduction ratio (R₀, average number of secondary infectious cases from a typical infectious case) was calculated from the growth rate of disease epidemics in broiler flocks. Assuming a latent period of 2 days and an infectious period of 4 days R₀ was estimated to be 2.43 (95% CI 2.25-2.69). In experimental settings the transmission characteristics of ΔgG ILTV were similar to those of wildtype virus, and importantly ΔgG ILTV remained safe following one in vivo passage and subsequent infection via contact-exposure. There was minimal transmission of wildtype virus in vaccinated birds. The findings from this study further demonstrate the suitability of ΔgG ILTV for use as a live attenuated vaccine. Knowledge of the basic reproduction ratio of ILTV will be valuable for future studies that aim to improve disease control using vaccination programs.
authors.affiliation: School of Veterinary Science, The University of Melbourne, Victoria 3010, Australia. devlinj@unimelb.edu.au
authors.forename: Joanne M
authors.initials: JM
authors.lastname: Devlin
authors.forename: Carol A
authors.initials: CA
authors.lastname: Hartley
authors.forename: James R
authors.initials: JR
authors.lastname: Gilkerson
authors.forename: Mauricio J C
authors.initials: MJ
authors.lastname: Coppo
authors.forename: Paola
authors.initials: P
authors.lastname: Vaz
authors.forename: Amir H
authors.initials: AH
authors.lastname: Noormohammadi
authors.forename: Ben
authors.initials: B
authors.lastname: Wells
authors.forename: Ambrosio
authors.initials: A
authors.lastname: Rubite
authors.forename: Navneet K
authors.initials: NK
authors.lastname: Dhand
authors.forename: Glenn F
authors.initials: GF
authors.lastname: Browning
mesh_terms: D000818:Animals; D002645:Chickens / Q000821:virology; D018562:Disease Transmission, Infectious / Q000517:prevention & control* / Q000662:veterinary; D006566:Herpesviridae Infections / Q000517:prevention & control / Q000635:transmission / Q000662:veterinary; D001352:Herpesvirus 1, Gallid / Q000235:genetics / Q000276:immunology*; D011201:Poultry Diseases / Q000276:immunology / Q000517:prevention & control / Q000821:virology; D014611:Vaccination; D014613:Vaccines, Attenuated / Q000276:immunology; D014759:Viral Envelope Proteins / Q000172:deficiency* / Q000235:genetics; D014765:Viral Vaccines / Q000276:immunology
chemical_list: D014613:Vaccines, Attenuated; D014759:Viral Envelope Proteins; D014765:Viral Vaccines; C067381:GB protein, Infectious laryngotracheitis virus